Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma
about
Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastomaU87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell lineMutational profiling of kinases in glioblastoma.Estrogen receptor alpha gene amplification in breast cancer: 25 years of debateNIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressorGenomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsA landscape of driver mutations in melanomaTargeting the hepatocyte growth factor-cMET axis in cancer therapyCaSNP: a database for interrogating copy number alterations of cancer genome from SNP array dataThe histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetComprehensive molecular characterization of human colon and rectal cancerRecent advances in the molecular understanding of glioblastomaConvergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancerCharacterizing the cancer genome in lung adenocarcinoma.Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesisComprehensive genomic characterization defines human glioblastoma genes and core pathwaysTargeting RTK Signaling Pathways in CancerMolecular characterizations of glioblastoma, targeted therapy, and clinical results to dateCancer stem cell division: when the rules of asymmetry are brokenRole of SOX family of transcription factors in central nervous system tumorsComputational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challengesBioinformatics for cancer immunology and immunotherapyThe consequences of chromosomal aneuploidy on the transcriptome of cancer cellsSynthetic lethal screens as a means to understand and treat MYC-driven cancersWill kinase inhibitors make it as glioblastoma drugs?Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research networkIntegrated genomic analyses of ovarian carcinomaMultiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaComprehensive molecular profiling of lung adenocarcinoma.PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingProportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cellsCDK8 is a colorectal cancer oncogene that regulates beta-catenin activityIntegrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomepiRNA involvement in genome stability and human cancerA systematic comparison of copy number alterations in four types of female cancerIntegrated DNA Copy Number and Gene Expression Regulatory Network Analysis of Non-small Cell Lung Cancer Metastasis
P2860
Q21134578-A072BCDE-B29D-4935-AF0D-34EA965A6FBBQ21144984-3C8FB18A-A343-4185-8B6F-B2F183608A26Q21261249-7B9F7303-4764-449C-8E4E-563A1B5E0FA3Q24273274-0600769E-0776-42D5-802C-1FC4F1A43C48Q24338837-84D66500-C20C-4A9A-8B7F-D6A286C94961Q24595882-7439094D-4297-49E7-BCA3-3AD24CFFF441Q24603357-B2E6175F-4486-4BC6-BCEB-ABA581E6A1CDQ24606259-DAC07E08-9BFE-4E34-AA36-84B9947F725DQ24607064-F78C3DFB-925F-48E9-AFD2-501D1C265334Q24625220-D2B1E2BF-AD8E-4D13-9C84-171A1FBE0235Q24630415-1B6A0402-E50A-40F0-B195-7EAADAC35E71Q24632928-849CBDE5-7DBA-4E3B-BD0B-248595D32F89Q24633517-D65A8C00-DDEC-4204-83F8-F2CCB9281466Q24649926-B9FE3A97-92DA-461D-BDFA-B96329CD58EFQ24651548-0F2BF533-0363-430F-A35C-421A0B273557Q24655172-1178954B-C54E-4395-9E10-2CB9D52C9C83Q24656128-B327D54A-CD5C-4363-AA24-AC766927B557Q26781278-AD75B85E-9300-4D0F-96F3-CE7DE791CA86Q26822717-4C272047-EB5E-48CE-9645-515C1FF5B8BCQ26851679-AA45717E-DBBC-440C-87B7-6DDEC547A34BQ26860974-52637EE6-5407-43B1-9425-C90DC5E0A5B2Q26864808-E4EC35DC-CE61-4976-87D3-1EB2FE136871Q26864876-518CCF85-D012-42D3-9500-56AB6EBC00E9Q26995532-AE566BBA-609C-4858-A717-A044745F36CDQ27006010-717DF783-E29D-4687-BBD1-8CB59DB5F304Q27012684-9ECB0313-53D8-42AB-BC00-477412CC0F73Q27322751-45C792BD-7AEB-4BB4-B006-90AE10DAD62BQ27851615-38122D55-D92C-4195-8908-5C8301539D1AQ27851654-14D2E06A-6FA1-4576-B2C6-F106B913CF7FQ27852242-BAC816DC-4A87-4DCE-9FFB-71EB663E49B5Q27860518-B8DD27F3-AC9F-42DE-8496-B3A037133C78Q28237604-555C0A2F-85D9-4611-8776-8E0084D837BBQ28244995-42B3DFFB-BA30-4830-B587-616FE2E4DC38Q28253621-55D859C7-F439-4BD0-94E0-0267FE8C57F1Q28257733-ECE0FAB1-2B88-421E-8655-D4D92B7A2959Q28294122-F96C3383-EF7D-426C-BBE3-9AD5A9608F80Q28298987-069F3189-7EDF-4A28-BD5F-3D09D2387906Q28392701-307D95B7-08B0-4E12-93AA-0D26E90D5BCDQ28394747-1A45CC42-EE8D-4B42-99BA-AD3E1A94E204Q28397049-A738E185-BE97-46E9-BBFD-AEA058D40BD1
P2860
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Assessing the significance of ...... logy and application to glioma
@ast
Assessing the significance of ...... logy and application to glioma
@en
type
label
Assessing the significance of ...... logy and application to glioma
@ast
Assessing the significance of ...... logy and application to glioma
@en
prefLabel
Assessing the significance of ...... logy and application to glioma
@ast
Assessing the significance of ...... logy and application to glioma
@en
P2093
P2860
P50
P3181
P356
P1476
Assessing the significance of ...... logy and application to glioma
@en
P2093
Charlie Hatton
David Linhart
Horacio Soto
Jeffrey C Lee
Julie H Huang
Kinjal Shah
Leia Nghiemphu
Linda Liau
P2860
P304
20007-20012
P3181
P356
10.1073/PNAS.0710052104
P407
P50
P577
2007-12-06T00:00:00Z